Cargando…
A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight
The number of low birthweight (LBW) infants weighing below 2500 g has not decreased in Japan. This study aimed to develop an adult non-obese hyperglycemic mouse model born with LBW to study the pathogenesis. At 16.5 days of gestation, transient intrauterine ischemia (blocked blood flow in both uteri...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312481/ https://www.ncbi.nlm.nih.gov/pubmed/35884949 http://dx.doi.org/10.3390/biomedicines10071642 |
_version_ | 1784753851103969280 |
---|---|
author | Katayama, Daichi Nagano, Nobuhiko Shimizu, Shoichi Nakazaki, Kimitaka Matsuda, Kengo Tokunaga, Wataru Fuwa, Kazumasa Aoki, Ryoji Morioka, Ichiro |
author_facet | Katayama, Daichi Nagano, Nobuhiko Shimizu, Shoichi Nakazaki, Kimitaka Matsuda, Kengo Tokunaga, Wataru Fuwa, Kazumasa Aoki, Ryoji Morioka, Ichiro |
author_sort | Katayama, Daichi |
collection | PubMed |
description | The number of low birthweight (LBW) infants weighing below 2500 g has not decreased in Japan. This study aimed to develop an adult non-obese hyperglycemic mouse model born with LBW to study the pathogenesis. At 16.5 days of gestation, transient intrauterine ischemia (blocked blood flow in both uterine arteries for 15 min) was performed in a subgroup of pregnant mice (group I). Non-occluded dams were used as sham controls (group C). After birth, female pups in each group were weaned at 4 weeks of age and reared on the normal diet until 8 weeks of age (n = 7). Fasting blood glucose levels, serum immunoreactive insulin (IRI), and body composition were then measured. Metabolite analyses was performed on the liver tissues. Birthweight was significantly lower in group I compared with group C. Pups from group I remained underweight with low fat-free mass and showed hyperglycemia with high serum IRI and homeostasis model assessment of insulin resistance levels, indicating insulin resistance. Metabolite analyses showed significantly reduced adenosine triphosphate and nicotinamide adenine dinucleotide production and increased lactic acid in group I. The pathogenesis of our non-obese hyperglycemic mouse model may be due to increased myogenic insulin resistance based on mitochondrial dysfunction and reduced lean body mass. |
format | Online Article Text |
id | pubmed-9312481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93124812022-07-26 A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight Katayama, Daichi Nagano, Nobuhiko Shimizu, Shoichi Nakazaki, Kimitaka Matsuda, Kengo Tokunaga, Wataru Fuwa, Kazumasa Aoki, Ryoji Morioka, Ichiro Biomedicines Article The number of low birthweight (LBW) infants weighing below 2500 g has not decreased in Japan. This study aimed to develop an adult non-obese hyperglycemic mouse model born with LBW to study the pathogenesis. At 16.5 days of gestation, transient intrauterine ischemia (blocked blood flow in both uterine arteries for 15 min) was performed in a subgroup of pregnant mice (group I). Non-occluded dams were used as sham controls (group C). After birth, female pups in each group were weaned at 4 weeks of age and reared on the normal diet until 8 weeks of age (n = 7). Fasting blood glucose levels, serum immunoreactive insulin (IRI), and body composition were then measured. Metabolite analyses was performed on the liver tissues. Birthweight was significantly lower in group I compared with group C. Pups from group I remained underweight with low fat-free mass and showed hyperglycemia with high serum IRI and homeostasis model assessment of insulin resistance levels, indicating insulin resistance. Metabolite analyses showed significantly reduced adenosine triphosphate and nicotinamide adenine dinucleotide production and increased lactic acid in group I. The pathogenesis of our non-obese hyperglycemic mouse model may be due to increased myogenic insulin resistance based on mitochondrial dysfunction and reduced lean body mass. MDPI 2022-07-08 /pmc/articles/PMC9312481/ /pubmed/35884949 http://dx.doi.org/10.3390/biomedicines10071642 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Katayama, Daichi Nagano, Nobuhiko Shimizu, Shoichi Nakazaki, Kimitaka Matsuda, Kengo Tokunaga, Wataru Fuwa, Kazumasa Aoki, Ryoji Morioka, Ichiro A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight |
title | A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight |
title_full | A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight |
title_fullStr | A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight |
title_full_unstemmed | A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight |
title_short | A Non-Obese Hyperglycemic Mouse Model that Develops after Birth with Low Birthweight |
title_sort | non-obese hyperglycemic mouse model that develops after birth with low birthweight |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312481/ https://www.ncbi.nlm.nih.gov/pubmed/35884949 http://dx.doi.org/10.3390/biomedicines10071642 |
work_keys_str_mv | AT katayamadaichi anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT naganonobuhiko anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT shimizushoichi anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT nakazakikimitaka anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT matsudakengo anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT tokunagawataru anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT fuwakazumasa anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT aokiryoji anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT moriokaichiro anonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT katayamadaichi nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT naganonobuhiko nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT shimizushoichi nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT nakazakikimitaka nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT matsudakengo nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT tokunagawataru nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT fuwakazumasa nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT aokiryoji nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight AT moriokaichiro nonobesehyperglycemicmousemodelthatdevelopsafterbirthwithlowbirthweight |